These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21537410)

  • 1. Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy study.
    Yoon KH; Shin JA; Kwon HS; Lee SH; Min KW; Ahn YB; Yoo SJ; Ahn KJ; Park SW; Lee KW; Sung YA; Park TS; Kim MS; Kim YK; Nam MS; Kim HS; Park IeB; Park JS; Woo JT; Son HY
    Diabetes Metab J; 2011 Feb; 35(1):26-33. PubMed ID: 21537410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of proton pump inhibitors on glycaemic control in diabetic patients.
    Rajput MA; Ali F; Zehra T; Zafar S; Kumar G
    J Taibah Univ Med Sci; 2020 Jun; 15(3):218-223. PubMed ID: 32647517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feature Selection in Predictive Modeling: A Systematic Study on Drug Response Heterogeneity for Type II Diabetic Patients.
    Chou J; Flory J; Wang F
    AMIA Jt Summits Transl Sci Proc; 2019; 2019():295-304. PubMed ID: 31258982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Concern on "The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone".
    Journal of Diabetes Research
    J Diabetes Res; 2019; 2019():2938413. PubMed ID: 31317045
    [No Abstract]   [Full Text] [Related]  

  • 5. Does Metformin Assist New Anti-Diabetic Drugs to Succeed?
    Kastuyama H; Yanai H
    J Clin Med Res; 2019 Feb; 11(2):151-155. PubMed ID: 30701009
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
    Kim HS; Kim DM; Cha BS; Park TS; Kim KA; Kim DL; Chung CH; Park JH; Jang HC; Choi DS
    J Diabetes Investig; 2014 Nov; 5(6):701-8. PubMed ID: 25422771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.
    Ferrannini E; Berk A; Hantel S; Pinnetti S; Hach T; Woerle HJ; Broedl UC
    Diabetes Care; 2013 Dec; 36(12):4015-21. PubMed ID: 24186878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures.
    Neutel JM; Zhao C; Karyekar CS
    Diabetes Ther; 2013 Dec; 4(2):269-83. PubMed ID: 23881432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride: evidence-based facts, trends, and observations (GIFTS). [corrected].
    Basit A; Riaz M; Fawwad A
    Vasc Health Risk Manag; 2012; 8():463-72. PubMed ID: 23028231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone.
    Srivastava S; Saxena GN; Keshwani P; Gupta R
    J Assoc Physicians India; 2012 Mar; 60():27-30. PubMed ID: 22799111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.
    Jeon HJ; Oh TK
    Diabetes Metab J; 2011 Oct; 35(5):529-35. PubMed ID: 22111045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.
    Moon JS; Kang S; Choi JH; Lee KA; Moon JH; Chon S; Kim DJ; Kim HJ; Seo JA; Kim MK; Lim JH; Song YJ; Yang YS; Kim JH; Lee YB; Noh J; Hur KY; Park JS; Rhee SY; Kim HJ; Kim HM; Ko JH; Kim NH; Kim CH; Ahn J; Oh TJ; Kim SK; Kim J; Han E; Jin SM; Bae J; Jeon E; Kim JM; Kang SM; Park JH; Yun JS; Cha BS; Moon MK; Lee BW
    Diabetes Metab J; 2024 Jul; 48(4):546-708. PubMed ID: 39091005
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.
    Jung I; Koo DJ; Lee WY
    Diabetes Metab J; 2024 May; 48(3):327-339. PubMed ID: 38310873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
    Choi JH; Lee KA; Moon JH; Chon S; Kim DJ; Kim HJ; Kim NH; Seo JA; Kim MK; Lim JH; Song Y; Yang YS; Kim JH; Lee YB; Noh J; Hur KY; Park JS; Rhee SY; Kim HJ; Kim HM; Ko JH; Kim NH; Kim CH; Ahn J; Oh TJ; Kim SK; Kim J; Han E; Jin SM; Choi WS; Moon MK
    Diabetes Metab J; 2023 Sep; 47(5):575-594. PubMed ID: 37793979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The forgotten type 2 diabetes mellitus medicine: rosiglitazone.
    Xu B; Xing A; Li S
    Diabetol Int; 2022 Jan; 13(1):49-65. PubMed ID: 35059243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
    Hur KY; Moon MK; Park JS; Kim SK; Lee SH; Yun JS; Baek JH; Noh J; Lee BW; Oh TJ; Chon S; Yang YS; Son JW; Choi JH; Song KH; Kim NH; Kim SY; Kim JW; Rhee SY; Lee YB; Jin SM; Kim JH; Kim CH; Kim DJ; Chun S; Rhee EJ; Kim HM; Kim HJ; Jee D; Kim JH; Choi WS; Lee EY; Yoon KH; Ko SH;
    Diabetes Metab J; 2021 Jul; 45(4):461-481. PubMed ID: 34352984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study.
    Saito T; Ohmura H; Nojiri S; Daida H
    J Pharm Health Care Sci; 2020; 6():13. PubMed ID: 32518665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.
    Kim MK; Ko SH; Kim BY; Kang ES; Noh J; Kim SK; Park SO; Hur KY; Chon S; Moon MK; Kim NH; Kim SY; Rhee SY; Lee KW; Kim JH; Rhee EJ; Chun S; Yu SH; Kim DJ; Kwon HS; Park KS;
    Diabetes Metab J; 2019 Aug; 43(4):398-406. PubMed ID: 31441247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women are less likely than men to achieve optimal glycemic control after 1 year of treatment: A multi-level analysis of a Korean primary care cohort.
    Choe SA; Kim JY; Ro YS; Cho SI
    PLoS One; 2018; 13(5):e0196719. PubMed ID: 29718952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program.
    Jeon JY; Lee SJ; Lee S; Kim SJ; Han SJ; Kim HJ; Kim DJ; Kim YS; Woo JT; Ahn KJ; Nam M; Baik SH; Park Y; Lee KW
    J Diabetes Investig; 2018 Sep; 9(5):1144-1152. PubMed ID: 29328551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.